TREE Insider Notice: 1,200 Restricted Shares to Be Sold via Morgan Stanley

Rhea-AI Filing Summary

LendingTree, Inc. (TREE) filed a Form 144 reporting a proposed sale of 1,200 restricted common shares. The shares were acquired as restricted stock on 06/12/2024 and fully paid the same day. The broker listed is Morgan Stanley Smith Barney LLC in New York. The filing lists an aggregate market value of $83,730.00 for the proposed sale, with the company showing 13,620,161 shares outstanding. The approximate sale date is 08/25/2025 and the securities exchange is NASDAQ. The filer reported no securities sold in the past three months and included the standard attestation that no undisclosed material adverse information is known.

Insights

Securities Analyst

TL;DR: Routine insider notice of a small restricted-stock sale; limited market impact given size.

The Form 144 documents a proposed sale of 1,200 restricted common shares valued at $83,730, indicating an insider or affiliated person intends to sell through Morgan Stanley Smith Barney LLC around 08/25/2025. The shares were acquired 06/12/2024 and fully paid at acquisition, consistent with ordinary equity compensation vesting and subsequent disposition. The filing discloses no other sales in the prior three months and includes the required attestation regarding material nonpublic information. This appears procedural rather than market-moving.

Compliance/Risk Analyst

TL;DR: Filing meets Rule 144 disclosure requirements; no compliance red flags within provided content.

The notice includes required details: acquisition date, nature (restricted stock), payment date, broker details, and outstanding share count. There are no reported aggregated sales in the past three months and the signer affirms lack of undisclosed material adverse information. From a compliance perspective, the form as presented is complete for the single proposed transaction and shows no apparent procedural omissions in the disclosed fields.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1200	83730.00	13620161	08/25/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/12/2024	Restricted Stock	Issuer			1200	06/12/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did LendingTree (TREE) report in this Form 144?

The filing reports a proposed sale of 1,200 restricted common shares valued at $83,730.00, to be sold via Morgan Stanley Smith Barney LLC on or about 08/25/2025 on NASDAQ.

When and how were the 1,200 shares acquired?

The shares were acquired as restricted stock from the issuer on 06/12/2024 and payment was recorded on the same date.

Does the filing show any other securities sold in the past three months?

No. The section for securities sold during the past three months states Nothing to Report.

How many LendingTree shares are outstanding according to this filing?

The filing lists 13,620,161 shares outstanding.

Who is the broker handling the proposed sale?

The broker named is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.